ArticleEuropean heart journal. Case reports2026
Intravascular lithotripsy for recurrent restenosis caused by a calcified nodule in a saphenous vein graft: a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Saphenous vein graft (SVG) lesions occurring in the chronic phase after coronary artery bypass graft (CABG) surgery are typically characterized by friable atherosclerotic plaques, whereas stenosis due to calcified nodules (CNs) is rare. Intravascular lithotripsy (IVL) is an effective treatment for severely calcified coronary artery lesions, but its application in SVG lesions remains limited. Case summary: An 84-year-old man with a history of two prior CABG procedures was referred to our hospital with angina pectoris. Coronary angiography revealed severe stenosis in the proximal segment of the SVG to the left anterior descending artery. Intravascular ultrasound demonstrated that a large CN was responsible for severe stenosis at the lesion site. Initial treatment consisted of drug-coated balloon (DCB) therapy following predilatation with a cutting balloon. Because restenosis occurred 9 months later, repeat DCB therapy following more aggressive lesion preparation with high-pressure non-compliant balloon dilatation was performed. Despite repeated DCB treatments, angiographic restenosis recurred 17 months after the initial intervention. Optical coherence tomography (OCT) confirmed a persistent CN, and IVL was performed using a 3.0 × 12 mm 'Shockwave' IVL balloon to modify the CN, followed by scoring balloon dilatation and implantation of a 3.5 × 28 mm drug-eluting stent. Final OCT demonstrated improved lumen expansion compared with previous interventions, with a favourable procedural outcome. Discussion: This case highlights the rarity of CNs in SVG lesions and suggests that IVL may be a reasonable treatment option for CNs in this setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.